Clinical Trials on 第一阶段:晚期或难治性实体瘤 in China
总计640个结果
-
Shanghai Pudong HospitalUTC Therapeutics Inc.撤销
-
Second Affiliated Hospital of Soochow UniversitySciClone Pharmaceuticals招聘中
-
Second Affiliated Hospital of Soochow University招聘中
-
Pfizer终止局部晚期或转移性实体瘤 | 基因,BRCA 1美国, 比利时, 西班牙, 丹麦, 日本, 法国, 意大利, 荷兰, 英国
-
Shijiazhuang Yiling Pharmaceutical Co. LtdTigermed Consulting Co., Ltd未知
-
Chinese PLA General Hospital未知
-
Chinese PLA General HospitalUTC Therapeutics Inc.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
Avistone Biotechnology Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; Peking University Cancer... 和其他合作者招聘中
-
Shanghai International Medical Center未知
-
Chinese PLA General HospitalWuxi Sinotide New Drug Discovery Institutes招聘中
-
Shanghai East HospitalImbioray (Hangzhou) Biomedicine Co., Ltd.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Jiangsu Simcere Pharmaceutical Co., Ltd.招聘中具有 NTRK、ROS1 或 ALK 基因融合的晚期或转移性实体瘤中国
-
Shanghai Miracogen Inc.招聘中
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中
-
Jiangsu Simcere Pharmaceutical Co., Ltd.未知
-
Zai Lab (Shanghai) Co., Ltd.Mirati Therapeutics Inc.主动,不招人
-
BeBetter Med IncXiangya Hospital of Central South University招聘中